Lead Toxicity: Symptoms and Treatment
Lead toxicity presents with a wide spectrum of multisystemic adverse effects ranging from subtle subclinical changes to life-threatening intoxication, requiring prompt identification and blood lead level-based treatment. 1
Symptoms of Lead Toxicity
Neurological Symptoms
- Cognitive dysfunction including memory problems, difficulty concentrating, and reduced intellectual capacity 1, 2
- Irritability and behavioral changes, particularly notable in children 2
- Headaches and dizziness 3
- In severe cases, lead encephalopathy with seizures, coma, and potential death 4
Gastrointestinal Symptoms
- Recurrent abdominal pain (a classic symptom of lead poisoning) 5, 6
- Constipation 3
- Nausea and vomiting 7
- Anorexia 3
Hematological Effects
- Anemia (often with basophilic stippling of red blood cells) 5, 6
- Elevated zinc protoporphyrin (ZPP) and delta-aminolevulinic acid levels 6, 8
Other Systemic Effects
- Hypertension 1, 2
- Renal dysfunction 1, 2
- Reproductive problems including decreased fertility 1, 2
- Fatigue and weakness 3
Diagnosis
- Blood lead level (BLL) is the primary diagnostic test for lead toxicity 2
- The triad for diagnosis includes: history of exposure, anemia with basophilic stippling, and recurrent abdominal pain 5
- Measurement of urinary delta-aminolevulinic acid and free erythrocyte protoporphyrin can support diagnosis 6
- Abdominal radiography should be considered for children with pica behavior 2
- Serum creatinine measurement to identify individuals with chronic renal dysfunction who may be at increased risk from lead exposure 1
Treatment Options
Removal from Exposure
- The first and most critical step in management is to identify and eliminate the source of lead exposure 2
- Adults should be removed from occupational exposure if repeat BLL measured in 4 weeks remains ≥20 μg/dL, or if first BLL ≥30 μg/dL 1
Chelation Therapy
- For children: Chelation therapy is indicated for BLLs above 45 μg/dL 2
- For adults: Chelation therapy is generally indicated for symptomatic patients with BLLs ≥70 μg/dL 2
- Adults with BLLs ≥100 μg/dL almost always warrant chelation, as these levels are often associated with significant symptoms 1
- Patients with BLLs of 80-99 μg/dL, with or without symptoms, should be considered for chelation 1
Chelating Agents
- Dimercaprol (BAL): For acute lead encephalopathy, 4 mg/kg body weight initially, followed by doses at four-hour intervals in combination with Edetate Calcium Disodium 4
- Succimer: Oral agent that can be used for less severe cases with BLLs >45 μg/dL 8
- Calcium Disodium EDTA: Often used in combination with dimercaprol for severe poisoning 8
- Contraindication: Dimercaprol should not be used in iron, cadmium, or selenium poisoning as the resulting complexes are more toxic than the metal alone 4
Supportive Care
- Nutritional support, particularly calcium supplementation during pregnancy which may decrease bone resorption and minimize release of lead from bone stores 1
- Monitoring of renal function and blood pressure 1
- Rehabilitation services (e.g., physical therapy, cognitive rehabilitation) may enhance recovery for patients with neurocognitive effects 1
Special Considerations
Pregnancy and Lactation
- Pregnant women should avoid lead exposure that would result in BLLs >5 μg/dL 1, 2
- Calcium supplementation during pregnancy is especially important for women with past exposure to lead 1
- Breastfeeding should be encouraged for most women, with decisions for those with very high lead exposure addressed individually 1
Follow-up Monitoring
- For BLLs 10-19 μg/dL: Test every 3 months, evaluate exposure and protective measures 1
- For BLLs ≥20 μg/dL: Monthly BLL testing until levels decline 1
- Consider return to lead work after 2 BLLs <15 μg/dL a month apart 1
Common Pitfalls in Diagnosis
- Lead poisoning is often misdiagnosed due to nonspecific symptoms 5
- Can be mistaken for acute porphyria due to similar symptoms and positive urine porphyrin tests 5
- Testing for heme precursors in urine is key to differentiating between lead poisoning and acute porphyria 5
- Detailed exposure history is crucial, as symptoms may appear long after initial exposure due to lead storage in bones 7, 8